Logistics & Transportation

Articles

Transaction expands CDMO’s services, including more solutions surrounding commercial manufacturing 

Five-year deal covers manufacturing of molecules, ranging from monoclonal antibodies to antibody-drug conjugates

Subject to regulatory approval, CDMO will produce mRNA vaccine on a commercial scale

Opens a ‘Cold Chain Packaging Center of Excellence’ in Kentucky, while expanding services globally

It’s not just innovator pharma companies concerned with the proposed compromise to Medicare price negotiations and inflation-based rebates

CDMO’s expansion of Hopkinton, MA facility will include seven new ISO 7 cGMP suites

Deal expected to boost firm’s offerings via FDS's delivery system services

Anticipated capacity of GMP facility is 60 million vials per year

Additional equipment to be added to the plant next year

Development project features additional manufacturing suites, expansion of storage capabilities